Patient Confidentiality Quotes

After all, why would a doctor worry about the confidentiality of her patient if she didn’t believe that patient was still alive?

What’s Lynparza? I know the other ones he takes, but not that one. What’s it do?” Her smile faded. “I can’t tell you that, Charlie. Patient confidentiality.” She slid behind the wheel. “But you could look it up on the Internet. Everything’s on the Net.

The moment I got a chance I slipped aside privately and touched an ancient common looking man on the shoulder and said, in an insinuating, confidential way: "Friend, do me a kindness. Do you belong to the asylum, or are you just on a visit or something like that?" He looked me over stupidly, and said: "Marry, fair sir, me seemeth—" "That will do," I said; "I reckon you are a patient.

Treating Abuse Today 3(4) pp. 26-33 TAT: No. I don't know anymore than you know they're not. But, I'm talking about boundaries and privacy here. As a therapist working with survivors, I have been harassed by people who claim to be affiliated with the false memory movement. Parents and other family members have called or written me insisting on talking with me about my patients' cases, despite my clearly indicating I can't because of professional confidentiality. I have had other parents and family members investigate me -- look into my professional background -- hoping to find something to discredit me to the patients I was seeing at the time because they disputed their memories. This isn't the kind of sober, scientific discourse you all claim you want.

But the history of Hopkins Hospital certainly isn’t pristine when it comes to black patients. In 1969, a Hopkins researcher used blood samples from more than 7,000 neighborhood children—most of them from poor black families—to look for a genetic predisposition to criminal behavior. The researcher didn’t get consent. The American Civil Liberties Union filed suit claiming the study violated the boys’ civil rights and breached confidentiality of doctor-patient relationships by releasing results to state and juvenile courts. The study was halted, then resumed a few months later using consent forms. And in the late nineties, two women sued Hopkins, claiming that its researchers had knowingly exposed their children to lead, and hadn’t promptly informed them when blood tests revealed that their children had elevated lead levels—even when one developed lead poisoning. The research was part of a study examining lead abatement methods, and all families involved were black. The researchers had treated several homes to varying degrees, then encouraged landlords to rent those homes to families with children so they could then monitor the children’s lead levels. Initially, the case was dismissed. On appeal, one judge compared the study to Southam’s HeLa injections, the Tuskegee study, and Nazi research, and the case eventually settled out of court. The Department of Health and Human Services launched an investigation and concluded that the study’s consent forms “failed to provide an adequate description” of the different levels of lead abatement in the homes.

In 1994, Friedman wrote a memo marked “Very Confidential” to Raymond, Mortimer, and Richard Sackler. The market for cancer pain was significant, Friedman pointed out: four million prescriptions a year. In fact, there were three-quarters of a million prescriptions just for MS Contin. “We believe that the FDA will restrict our initial launch of OxyContin to the Cancer pain market,” Friedman wrote. But what if, over time, the drug extended beyond that? There was a much greater market for other types of pain: back pain, neck pain, arthritis, fibromyalgia. According to the wrestler turned pain doctor John Bonica, one in three Americans was suffering from untreated chronic pain. If that was even somewhat true, it represented an enormous untapped market. What if you could figure out a way to market this new drug, OxyContin, to all those patients? The plan would have to remain secret for the time being, but in his memo to the Sacklers, Friedman confirmed that the intention was “to expand the use of OxyContin beyond Cancer patients to chronic non-malignant pain.” This was a hugely audacious scheme. In the 1940s, Arthur Sackler had watched the introduction of Thorazine. It was a “major” tranquilizer that worked wonders on patients who were psychotic. But the way the Sackler family made its first great fortune was with Arthur’s involvement in marketing the “minor” tranquilizers Librium and Valium. Thorazine was perceived as a heavy-duty solution for a heavy-duty problem, but the market for the drug was naturally limited to people suffering from severe enough conditions to warrant a major tranquilizer. The beauty of the minor tranquilizers was that they were for everyone. The reason those drugs were such a success was that they were pills that you could pop to relieve an extraordinary range of common psychological and emotional ailments. Now Arthur’s brothers and his nephew Richard would make the same pivot with a painkiller: they had enjoyed great success with MS Contin, but it was perceived as a heavy-duty drug for cancer. And cancer was a limited market. If you could figure out a way to market OxyContin not just for cancer but for any sort of pain, the profits would be astronomical. It was “imperative,” Friedman told the Sacklers, “that we establish a literature” to support this kind of positioning. They would suggest OxyContin for “the broadest range of use.” Still, they faced one significant hurdle. Oxycodone is roughly twice as potent as morphine, and as a consequence OxyContin would be a much stronger drug than MS Contin. American doctors still tended to take great care in administering strong opioids because of long-established concerns about the addictiveness of these drugs. For years, proponents of MS Contin had argued that in an end-of-life situation, when someone is in a mortal fight with cancer, it was a bit silly to worry about the patient’s getting hooked on morphine. But if Purdue wanted to market a powerful opioid like OxyContin for less acute, more persistent types of pain, one challenge would be the perception, among physicians, that opioids could be very addictive. If OxyContin was going to achieve its full commercial potential, the Sacklers and Purdue would have to undo that perception.

unique to three areas: medical, pharmaceutical and basic research. Medical ethics covers informed consent, doctor-patient confidentiality, and organ donation, to name a few. “Outsourcing Medical Studies—and Ethical Quandaries—to Africa” by David Biello delves into the lack of medical ethics boards in Africa and how this affects participant safety

hand, the fact that he’s still practically a stranger makes it…better, somehow.

I don’t want the surgery.

A small wave of guilt washes over me at the absence of the wedding band on his ring finger, but the feeling is laced with a smidgen of…something else. Relief? Comfort? I don't know. All I do know is it's strange and confusing and—

Doctor-patient confidentiality stated she was protected from crimes of her past if she confessed them to me. Unless she admitted she was about to carry out a crime, her secret was safe with me.

I appreciate that,” Myron said, “but I actually wanted to talk to you about another matter.” “Please.” He leaned back, folded his hands in his lap, smiled. “Go right ahead.” “It’s about Greg Downing.” The smile didn’t budge, but the light behind it flickered a bit. “Greg Downing?” “Yes. I have a few questions.” Still smiling. “You realize, of course, that I cannot reveal anything that may fall under what I consider privileged.” “Of course,” Myron agreed. “I was wondering if you could tell me where he is.” Marty Felder waited a beat. This was no longer a sales pitch meeting. It was now a negotiation. A good negotiator is frighteningly patient. Like a good interrogator, he must above all else be a listener. He must make his opponent do the talking. After several seconds, Felder asked, “Why do you want to know that?” “I need to speak with him,” Myron said. “May I ask what this is about?” “I’m afraid it’s confidential.” They

Marry me," he said. Her eyes widened. "What?" She nearly fell off the horse. "Marry me, Kate," he repeated. He swallowed hard. "I need you in my life. Please. Say you'll be my duchess." "Rohan..." He took a step closer. "I know I said some boorish, stupid things that day in the music room. You were right. I was scared. I didn't know how it could be between us, but I see it now. And that night on your father's ship, I acted like a brute, telling you to prove your love by sleeping with me. It was wrong." She shook her head. "You needed me." "I did. I still do. I always will. I don't know what I'll do if you say no." He lowered his head. "I know you've reason to be wary. That I can be a thoroughgoing bastard sometimes. I've had too many women in the past, but, God, I don't want that anymore. And it is true, I, er, kill people now and then, but just to safeguard England. And if you can live with that---" He shook his head with a tempestuous fire in his eyes. "On my word, I will be true to you, and I will love you until the end of time." Kate had lost the power of speech. Indeed, she could barely breathe. Tears rushed into her eyes. Lord Byron himself could not have uttered more romantic sentiments. "There can be no other for me, Kate, but you." The Beast walked over and stared hard into the depths of her eyes; sitting on the pony's back, she was on eye level with him for once, and the whole tumult of his soul was there in his eyes, discovering love for the first time, setting his heart free at last. "You... make me feel things I've never experienced before. You've been so patient, and I've been such a fool." "No, you haven't," she breathed, wonder-struck by him. Was this just a dream? "Stay with me always," he implored her in a confidential whisper. "And love me... as I love you." "You---love me?" she echoed, her chin trembling in the most embarrassing fashion. "With all my heart," he vowed in a soft but fierce tone, looking as deeply moved as she. He touched her hair, tucking a windblown lock of it behind her ear. "Kate, you and I were meant to be together. I'm still superstitious enough to know when I have found my destiny. It's you. You're the one who broke the curse.

If doctors as a whole aren’t bound by a duty of confidentiality, patients generally will be less forthcoming, and the general confidence that the public reposes in the medical profession will be reduced.

A consultant I once worked for was renowned for his warmth and kindness. (..) A colleague told me, confidentially, that this same consultant was also in charge of a ward located in another hospital where patients were bound in restraints, force-fed and abused by a team of sadistic nurses. (..) Was the kindly consultant for whom I had so much respect an authentic Jekyll and Hyde? I doubt I would have remembered this story—it still sounds to me like an urban legend—were it not for the fact that I had had first-hand experience of equally odd characters and situations in other hospital settings.